High levels of interferon-gamma (IFNγ) in macrophage activation syndrome (MAS) and CXCL9 levels as a biomarker for IFNγ production in MAS

C. Bracaglia; D. Pires Marafon; I. Caiello; K. de Graaf; F. Guilhot; W. Ferlin; S. Davì; G. Schulert; A. Ravelli; A. Grom; R. Nelson; C. de Min; F. De Benedetti

Journal ArticleOPEN ACCESS

High levels of interferon-gamma (IFNγ) in macrophage activation syndrome (MAS) and CXCL9 levels as a biomarker for IFNγ production in MAS

Bracaglia C
Marafon D
Caiello I
et al.

Pediatric Rheumatology (2015) 13(1)

DOI: 10.1186/1546-0096-13-S1-O84

7Citations

15Readers

Cite

CITATION STYLE

APA

Bracaglia, C., Marafon, D. P., Caiello, I., de Graaf, K., Guilhot, F., Ferlin, W., … De Benedetti, F. (2015). High levels of interferon-gamma (IFNγ) in macrophage activation syndrome (MAS) and CXCL9 levels as a biomarker for IFNγ production in MAS. Pediatric Rheumatology, 13(1). https://doi.org/10.1186/1546-0096-13-S1-O84

High levels of interferon-gamma (IFNγ) in macrophage activation syndrome (MAS) and CXCL9 levels as a biomarker for IFNγ production in MAS

Cite

Register to see more suggestions